Evidence map›Paper›PMID 41131093›Full record

ArticleScientific reports2025

Quantum-resilient and adaptive multi-region data aggregation for IoMT using zero-knowledge proofs and edge intelligence.

Soufiane Ben Othman, Gyanendra Kumar

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Soufiane Ben OthmanApplied College, King Faisal University, 31982, Al-Ahsa, Saudi Arabia. sbenothman@kfu.edu.sa.
Gyanendra KumarDepartment of IoT and Intelligent Systems, Manipal University Jaipur, Jaipur, India. gyanendra.kumar@jaipur.manipal.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Internet of Medical Things (IoMT) transforms healthcare by enabling real-time monitoring of patient vitals, such as heart rate and glucose levels, but faces significant challenges in securing sensitive data against cyber threats and ensuring reliability in resource-constrained wearable devices, like low-power biosensors with limited computational capacity. The rise of quantum computing, particularly Shor algorithm, threatens to break traditional cryptographic methods (e.g., RSA, ECC) within 5–10 years by efficiently solving their underlying mathematical problems, endangering patient data confidentiality. Post-quantum cryptography (PQC), such as lattice-based schemes, offers resilience but demands high computational resources, challenging IoMT scalability. Unlike other PQC IoMT frameworks, such as those using NTRU, which prioritize computational simplicity but lack advanced privacy mechanisms, Q-PRADAX pioneers a secure, adaptive data aggregation framework, integrating Ring-LWE-based PQC for quantum-resilient confidentiality, compact zk-SNARK proofs for tamper-proof verification of patient vitals, and adaptive clustering for enhanced network reliability and scalability. Evaluated using OMNeT + + 6.0.3 with INET 4.5, Q-PRADAX achieves 94.5% diagnostic accuracy on ECG datasets, 100% tampering detection, and 99.9% packet delivery across 1000 devices in its Baseline scenario, with a security latency of 12.2 ms/packet and energy consumption of 0.38 mJ/packet on ARM Cortex-M4 devices (200 mAh). Outperforming existing IoMT solutions in security and fault tolerance, Q-PRADAX establishes a global standard for a secure, patient-centric IoMT ecosystem, redefining reliable healthcare delivery.

Indexed as

Adaptive clusteringFault toleranceIoMT securityPost-Quantum cryptographyZk-SNARK proofs

Identifiers

PMID41131093
PMCPMC12549865

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.